All Report
Whether you’re exploring new opportunities, responding to change, or planning your next move—we’re here to help you make sense of it all. Our research goes beyond data to uncover real market signals, emerging trends, competitive shifts, and what they mean for your business. With practical insights and a partner mindset, we support you in making smarter, faster, and more confident decisions.
The global cancer registry software market is projected to achieve significant growth, with its valuation expected to rise from USD 88.4 million in 2024 to USD 237.0 million by 2034, growing at a robust CAGR of 11.4%.
The global cancer tissue diagnostics market is projected to exhibit substantial growth, with its estimated value rising from USD 15,303.2 million in 2024 to USD 23,517.2 million by 2034, reflecting a CAGR of 5.5% during the forecast period.
The global cancer vaccines market is poised for robust growth, with its valuation expected to reach USD 10 billion in 2024 and grow to USD 25.22 billion by 2034, registering a CAGR of 13% over the forecast period.
The global cancer-focused genetic testing service market is set to achieve a valuation of USD 9.5 billion in 2024, growing to USD 20.3 billion by 2034, with a compound annual growth rate (CAGR) of 9.6% over the forecast period.
The global canine arthritis treatment market is projected to grow significantly, reaching a valuation of USD 2.51 billion in 2024 and surging to USD 3.78 billion by 2034
The global market for canine atopic dermatitis treatment is projected to grow from USD 1,183.6 million in 2024 to USD 1,621.5 million by 2034, achieving a compound annual growth rate (CAGR) of 4.2% over the forecast period.
The global canine cancer screening market is projected to experience robust growth, with its valuation increasing from USD 1.40 billion in 2024 to USD 2.09 billion by 2034.
The global cannabis use disorder (CUD) treatment market is projected to grow significantly, with a market value expected to increase from USD 1.66 billion in 2024 to USD 2.67 billion by 2034, showcasing a robust CAGR of 5.9% over the forecast period.
The global capnography equipment market is anticipated to experience significant growth, expanding from USD 335 million in 2024 to USD 537 million by 2034, at an updated CAGR of 5.4%.
The global market for canine dilated cardiomyopathy (DCM) drugs is poised to grow from USD 3,644.6 million in 2024 to USD 5,823.9 million by 2034, reflecting a CAGR of 5.8% over the forecast period.